This brand name is authorized in Estonia, Spain, France, Malta, Poland, Romania
The drug TEKTROTYD contains one active pharmaceutical ingredient (API):
| 1 Technetium ⁹⁹ᵐTc hynic-octreotide |
|
Technetium ⁹⁹ᵐTc hynic-octreotide is for diagnostic use only. Technetium (99mTc) labelled EDDA/HYNIC-TOC binds with high affinity to somatostatin receptor subtypes 2 and 5, also to subtype 3 but with lesser affinity. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V09IA07 | V Various → V09 Diagnostic radiopharmaceuticals → V09I Tumour detection → V09IA Technetium (99mTc) compounds | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1681680 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 80718 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 61249354 |
| Country: MT | Medicines Authority | Identifier(s): MA1214/00301 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100138327, 100341488 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W63076001 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
